At the dose we used, neither MC38-EVs nor MC38 Pdl1−/−-EVs promoted tumor growth, suggesting that MC38-EVs indeed blunted the antitumor effect of αPD-L1 by consuming αPD-L1 rather than directly inhibiting antitumor immunity (Supplementary Fig. 3d). This evidence concerns the gene CD274 and neoplasm.